Ophthalmology
Ophthalmology
Audio Summaries
Every issue of Ophthalmology moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Ophthalmology.
Polygenic risk impacts lifetime risk and prognosis of glaucoma
Jun 11, 2026
The authors aimed to evaluate the clinical utility of a glaucoma polygenic risk score (PRS) in assessing glaucoma risk, age at onset, and prognosis in a large cohort of individuals. They found that the best-performing PRS significantly stratified lifetime glaucoma risk and correlated with the need for more intensive glaucoma care, outperforming family history alone. These results suggest that PRS could enhance screening and management strategies for glaucoma, warranting further prospective studies.
Large Language Model Authorship in Ophthalmic Publications
Jun 4, 2026
The authors aimed to investigate the prevalence of AI-generated text in ophthalmology publications following the release of ChatGPT in 2022. Their analysis revealed a significant increase in stylistic word usage associated with AI-generated content, with 25.7% of research articles and 21.6% of commentary articles showing high likelihoods of AI authorship, often without disclosure. The findings highlight the need for transparency and editorial oversight regarding the use of AI in scientific writing to maintain authorship integrity.
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study
Jun 2, 2026
The authors aimed to investigate the association between semaglutide use and the risk of neovascular age-related macular degeneration (NVAMD) in adults with type 2 diabetes. Their retrospective study, utilizing data from the OHDSI network, found no significant differences in NVAMD risk between semaglutide users and those using other diabetes medications, suggesting that semaglutide does not increase or decrease the risk of NVAMD.